PTPRε Acts as a Metastatic Promoter in Hepatocellular Carcinoma by Facilitating Recruitment of SMAD3 to TGF‐β Receptor 1
Zhibin Liao,Lin Chen,Xuewu Zhang,Hongwei Zhang,Xiaolong Tan,Keshuai Dong,Xun Lu,He Zhu,Qiumeng Liu,Zhanguo Zhang,Zeyang Ding,Wei Dong,Peng Zhu,Liang Chu,Huifang Liang,Pran K. Datta,Bixiang Zhang,Xiaoping Chen
DOI: https://doi.org/10.1002/hep.31104
IF: 17.298
2020-09-01
Hepatology
Abstract:<p>Transforming growth factor beta (TGF‐β) suppresses early stages of tumorigenesis, but contributes to migration and metastasis of cancer cells. However, the role of TGF‐β signaling in invasive prometastatic hepatocellular carcinoma (HCC) is poorly understood. In this study, we investigated the roles of canonical TGF‐β/SMAD3 signaling and identified downstream effectors on HCC migration and metastasis. By using <i>in vitro</i> trans‐well migration and invasion assays and <i>in vivo</i> metastasis models, we demonstrated that SMAD3 and Protein Tyrosine Phosphatase Receptor Epsilon (PTPRε) promotes migration, invasion and metastasis of HCC cells <i>in vitro</i> and <i>in vivo</i>. Further mechanistic studies revealed that, upon TGF‐β stimulation, SMAD3 binds directly to PTPRε promoters to activate its expression. PTPRε interacts with TGFBR1/SMAD3 and facilitates recruitment of SMAD3 to TGFBR1, resulting a sustained SMAD3 activation status. The tyrosine phosphatase activity of PTPRε is important for binding with TGFBR1, recruitment and activation of SMAD3, and its prometastatic role <i>in vitro</i>. A positive correlation between pSMAD3/SMAD3 and PTPRε expression were determined in HCC samples, and high expression of SMAD3 or PTPRε was associated with poor prognosis of HCC patients. <b>Conclusion</b></p><p>PTPRε positively feedback regulates TGF‐β/SMAD3 signaling to promote HCC metastasis.</p>
gastroenterology & hepatology